Search
Search Results
##search.searchResults.foundPlural##
-
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1663PDF: 680HTML: 1392 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3674PDF: 1587HTML: 4498CoverLetter: 204Figure1: 221 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3707PDF: 2593HTML: 1615 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1150PDF: 1267HTML: 118 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1010PDF: 550HTML: 222 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2153PDF: 803HTML: 3255 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
4065PDF: 2005HTML: 273 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4167PDF: 1296HTML: 2118Table 1: 219 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1356PDF: 1083HTML: 425 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2281PDF: 1665HTML: 544 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1345PDF: 1116HTML: 248 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
923PDF: 536HTML: 239Suppl. Files: 341 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4915PDF: 1860HTML: 2865Untitled: 251 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7819PDF: 2481HTML: 2115Table 1.: 246Table 2.: 257Table 3.: 237Table 4.: 232 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1468PDF: 852HTML: 8672Fig 3 Savini: 200Fig 2 Savini: 206Fig 1 Savini Chest TC: 205Author letter to referees: 210 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1103PDF: 584HTML: 7881 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1276PDF: 625HTML: 2907ATRA induced Reactive Hemophagocytosis: A Case Report: 220 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2649PDF: 977HTML: 581 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4155PDF: 1197HTML: 2106Fig.1: 228Fig. 2: 123Table 1: 224Table2: 243Table 3: 223 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12936PDF: 1730HTML: 4350Cover letter: 222Figure 1: 231 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1655PDF: 1102HTML: 467 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1792PDF: 1319HTML: 613







